These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33375253)

  • 21. Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction.
    Tal R; Shaish A; Barshack I; Polak-Charcon S; Afek A; Volkov A; Feldman B; Avivi C; Harats D
    Am J Pathol; 2010 Dec; 177(6):2950-62. PubMed ID: 20952590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomes From Women With Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells.
    Chang X; Yao J; He Q; Liu M; Duan T; Wang K
    Hypertension; 2018 Dec; 72(6):1381-1390. PubMed ID: 30571229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
    Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of soluble endoglin in BMP9 signaling.
    Lawera A; Tong Z; Thorikay M; Redgrave RE; Cai J; van Dinther M; Morrell NW; Afink GB; Charnock-Jones DS; Arthur HM; Ten Dijke P; Li W
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17800-17808. PubMed ID: 31431534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction.
    Kadyrov M; Kingdom JC; Huppertz B
    Am J Obstet Gynecol; 2006 Feb; 194(2):557-63. PubMed ID: 16458661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why is placentation abnormal in preeclampsia?
    Fisher SJ
    Am J Obstet Gynecol; 2015 Oct; 213(4 Suppl):S115-22. PubMed ID: 26428489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction.
    Stepan H; Krämer T; Faber R
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2831-4. PubMed ID: 17426082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GNG7 silencing promotes the proliferation and differentiation of placental cytotrophoblasts in preeclampsia rats through activation of the mTOR signaling pathway.
    Lai WS; Ding YL
    Int J Mol Med; 2019 May; 43(5):1939-1950. PubMed ID: 30864685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia.
    Li H; Yao J; Chang X; Wu J; Duan T; Wang K
    Reproduction; 2018 Mar; 155(3):297-306. PubMed ID: 29363569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
    Luo X; Liu DD; Qi HB; Yao ZW
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Traditional and New Routes of Trophoblast Invasion and Their Implications for Pregnancy Diseases.
    Huppertz B
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction.
    Silver KL; Conroy AL; Leke RG; Leke RJ; Gwanmesia P; Molyneux ME; Taylor DW; Rogerson SJ; Kain KC
    PLoS One; 2011; 6(9):e24985. PubMed ID: 21966395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.
    Hastie R; Ye L; Hannan NJ; Brownfoot FC; Cannon P; Nguyen V; Tong S; Kaitu'u-Lino TJ
    Pregnancy Hypertens; 2018 Oct; 14():125-130. PubMed ID: 30527099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
    Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
    Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sildenafil citrate on circulating levels of sFlt-1 in preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Cannon P; Nguyen V; Kaitu'u-Lino TJ
    Pregnancy Hypertens; 2018 Jul; 13():1-6. PubMed ID: 30177033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia.
    Zhou CC; Irani RA; Zhang Y; Blackwell SC; Mi T; Wen J; Shelat H; Geng YJ; Ramin SM; Kellems RE; Xia Y
    Circulation; 2010 Jan; 121(3):436-44. PubMed ID: 20065159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of placental-derived fetal growth restriction.
    Burton GJ; Jauniaux E
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S745-S761. PubMed ID: 29422210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
    Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.